Insider · CIK 0001802419
Robert J. Phelan
cfoofficer
Files at CVSA (Adtalem Global Education Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 23, 2025 | CVSA Adtalem Global Education Inc. | AGrant or award Common Stock | +21,555 | $134.88 | $2.9M | 65,458 | Aug 27, 2025 |
| Aug 23, 2025 | CVSA Adtalem Global Education Inc. | FTax withholding Common Stock | -9,537 | $134.88 | $1.3M | 55,921 | Aug 27, 2025 |
| Aug 23, 2025 | CVSA Adtalem Global Education Inc. | FTax withholding Common Stock | -1,279 | $134.88 | $173k | 54,642 | Aug 27, 2025 |
| Aug 24, 2025 | CVSA Adtalem Global Education Inc. | FTax withholding Common Stock | -1,414 | $134.88 | $191k | 53,228 | Aug 27, 2025 |
| Aug 24, 2025 | CVSA Adtalem Global Education Inc. | AGrant or award Common Stock | +19,305 | $134.88 | $2.6M | 72,533 | Aug 27, 2025 |
| Aug 24, 2025 | CVSA Adtalem Global Education Inc. | FTax withholding Common Stock | -8,553 | $134.88 | $1.2M | 63,980 | Aug 27, 2025 |
| Aug 25, 2025 | CVSA Adtalem Global Education Inc. | FTax withholding Common Stock | -173 | $135.33 | $23k | 63,807 | Aug 27, 2025 |
| Nov 13, 2024 | CVSA Adtalem Global Education Inc. | AGrant or award Common Stock | +4,220 | $89.85 | $379k | 43,903 | Nov 15, 2024 |
| Nov 10, 2024 | CVSA Adtalem Global Education Inc. | FTax withholding Common Stock | -1,622 | $91.23 | $148k | 39,683 | Nov 13, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.